UPDATE : Monday, November 18, 2019
상단여백
Sale of Novartis’ conjunctivitis drug Pataday banned for 3 months
The Ministry of Food and Drug Safety has suspended the sale of Novartis Kor...
by Lee Hye-seon  |  2019-09-30 11:25
라인
Investor trust in bio-industrialists sank due to latter’s unethical acts
The biotech industry is losing trust from investors as some executives at t...
by Lee Han-soo  |  2019-09-27 15:11
라인
Genexine sets up joint firm in Thailand
Genexine said that it has established KinGen Biotech in Thailand, a joint v...
by Lee Han-soo  |  2019-09-26 17:00
라인
[Analysis] Successive failures throw Korean bioindustry's drug-developing ability into question
The recent failures by Korean biotech companies to reach meaningful results...
by Lee Han-soo  |  2019-09-26 15:39
라인
Pfizer’s leukemia therapy Besponsa to get insurance benefit
The government said it would grant insurance benefit to Pfizer’s leukemia t...
by Kim Yun-mi  |  2019-09-26 11:26
라인
'Xtandi emerges as convenient treatment option for prostate cancer patients'
Astellas Korea is strengthening its position in the local prostate cancer m...
by Lee Han-soo  |  2019-09-25 17:39
라인
Huons, Lipac Oncology to co-develop bladder cancer treatment
Huons said that it has signed an exclusive licensing agreement for developi...
by Lee Han-soo  |  2019-09-25 11:18
라인
AstraZeneca releases detailed results of P3 trial of SGLT2 inhibitor
AstraZeneca announced detailed results of the landmark phase 3 DAPA-HF tria...
by Lee Han-soo  |  2019-09-24 18:08
라인
Qurient enrolls patients for trials of atopy treatment
Qurient said Tuesday that it has completed patient enrollment for phase 2b ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Hanmi’s US partner to unveil results of anticancer drug study
Hanmi Pharmaceutical said that Athenex, its U.S. partner, plans to present ...
by Lee Han-soo  |  2019-09-24 17:00
라인
Why using end-to-end services should be part of a drug product strategy
Specialized services offered by end-to-end service providers are essential ...
by Lee Han-soo  |  2019-09-24 16:54
라인
Helixmith's fails to end P3 trials of diabetic peripheral neuropathy treatment
Helixmith said that it has failed to make conclusions due to data contamina...
by Lee Han-soo  |  2019-09-24 16:38
라인
Hwail, SupexBNP wins patent for neutropenia treatment in US
Hwail Pharmaceutical and SupexBNP said that they have registered a patent f...
by Lee Han-soo  |  2019-09-23 22:34
라인
Drug firms uncertain about pricing of quadrivalent flu vaccines
As the 2019-2020 flu season approaches, pharmaceutical firms are engaging i...
by Jeong Sae-im  |  2019-09-23 14:52
라인
Roche’s Tecentriq becomes 1st immunotherapy to win indication for SCLC
Roche Korea has received approval from the Ministry of Food and Drug Safety...
by Lee Han-soo  |  2019-09-23 13:28
라인
‘Diabetes treatment Forxiga born as new heart drug in DAPA-HF study’
“The DAPA-HF trial results announced in the recent European Society of Card...
by Kim Yun-mi  |  2019-09-23 11:45
라인
‘Daewoong’s diabetes therapy proves superior blood-sugar-lowering effect to existing drugs’
Daewoong Pharmaceutical said its poster session on phase 1 clinical trial o...
by Lee Han-soo  |  2019-09-20 17:51
라인
Dongwha could lose ₩60 billion sales as GSK ends deal
Dongwha Pharmaceutical faces a steep decrease in sales as GSK Consumer Heal...
by Lee Han-soo  |  2019-09-20 14:28
라인
Novo Nordisk releases trial result for basal insulin analog injection
Novo Nordisk said it has presented the global head-to-head trial called CON...
by Lee Han-soo  |  2019-09-20 12:27
라인
Multinational pharmaceuticals continue to increase R&D spending in Korea
The Korea Research-based Pharma Industry Association (KRPIA) said that the ...
by Lee Han-soo  |  2019-09-19 17:15
여백
여백
여백
Back to Top